Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/25 20:25 | 1/29/24 | RLAY | Health | BioPrd | Biological Products, (No Diag | Rahmer Peter | MA | O | See rema | 14 | S.m | -1,528 | 5.70 | 0 | -268 | 515 | D | |||||||||||||||
4/30/25 20:24 | 1/29/24 | RLAY | Health | BioPrd | Biological Products, (No Diag | Catinazzo Thomas | MA | O | CFO | 12 | S.m | -653 | 5.10 | 0 | -128 | 379 | D | |||||||||||||||
4/30/25 20:24 | 1/29/24 | RLAY | Health | BioPrd | Biological Products, (No Diag | Bergstrom Donald A | MA | O | P,R,D | 12 | S.m | -577 | 4.51 | 0 | -128 | 616 | D | |||||||||||||||
4/30/25 20:23 | 1/29/24 | RLAY | Health | BioPrd | Biological Products, (No Diag | Adams Brian | MA | O | GC | 12 | S.m | -358 | 4.60 | 0 | -78 | 406 | D | |||||||||||||||
4/24/25 16:03 | 4/23/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Patel Sanjiv | MA | DO | P,CEO | 5 | S.dm | -4,054 | 4.83 | 0 | -839 | 2,128 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |